Share this event on:

Genome Editing of Stem Cells

This presentation is now available to view on-demand

Human pluripotent stem cells (hPSCs) carrying disease-associated genetic defects hold great potential for interrogating the molecular basis of human disease. In recent years, the rapid development of engineered nucleases and their use to introduce or correct such disease-causing mutations in hPSCs has significantly broadened the spectrum of diseases that can be modeled. An overview of TALEN and CRISPR based technology and their application in models of genetic disease will be the focus of a forthcoming webinar presented by Cell Press on “Genome editing of stem cells” on June 27th. We hope that you will join us for the chance to hear from Chad Cowan, Joseph Wu and Feng Zhang on the latest findings in this rapidly moving area of the stem cell field.

Who should attend:

Anyone interested in genetic engineering of stem cells to study the molecular basis of disease, or to generate screening platforms for potential therapeutics

Registration Details:


Dr. Chad Cowan
Harvard Stem Cell Inst.
View Bio
Dr. Joseph Wu
Stanford Cardiovascular Institute
View Bio
Dr. Feng Zhang
Broad and McGovern Institutes

View Bio
Dr. Kiki Lilliehook
Senior Scientific Editor
Cell Stem Cell
By registering for this webinar, you consent to your personal data being used by Elsevier B.V., its affiliates worldwide, and the above funding entity(ies) to provide you with information about related programs, products, and services. *

Our registration process uses cookies; by submitting this registration form you agree to our cookie policy.

(*) required fields